Infarco SA Sustainability Reports

Infarco, Sa operates as a corporate holding group primarily focused on the pharmaceutical and biotechnology sectors. Its major operating subsidiary is Laboratorios Cinfa, S.A., a leading manufacturer of generic medicines and healthcare solutions in Spain.

Sector: Finance & insurance

Country: Spain

Exchange: Unlisted

LEI: 959800575WHRA8D2VN46

5 reports from 2021 to 2025

• Infarco SA 2025 Non-Financial Information Statement
• Infarco SA 2024 Executive Summary of Non-Financial Information Statement
• Infarco SA 2023 Non-Financial Information Statement
• Infarco SA 2022 Sustainability Report
• Infarco SA 2021 Corporate Sustainability Report